WuXi XDC Cayman Inc
2268
Kedudukan dalam Saham
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Harga Saham
$8.78
Modal Pasaran
$11.12B
Perubahan (1 hari)
-9.52%
Perubahan (1 tahun)
0.57%
Negara
CN
Perdagangan WuXi XDC Cayman Inc (2268)
Kategori
Healthcare
Nisbah P/B bagi WuXi XDC Cayman Inc (2268)
Nisbah P/B pada October 2026 TTM: 6.53
Menurut laporan kewangan dan harga saham terkini WuXi XDC Cayman Inc, nisbah P/B semasa (TTM) ialah 6.53. Pada akhir 2024, nisbah P/B syarikat ialah 5.20.
Sejarah nisbah P/B untuk WuXi XDC Cayman Inc dari 2020 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 6.53 | -2.87% |
| 2025 | 6.72 | 29.37% |
| 2024 | 5.20 | -10.37% |
| 2023 | 5.80 | -70.54% |
| 2022 | 19.68 | -98.47% |
| 2021 | 1.29K | 1,641.63% |
| 2020 | 73.89 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 4.7411 | -27.36% |
US
|
|
| 3.0143 | -53.82% |
US
|
|
| 31.051 | 375.74% |
US
|
|
| 4.9326 | -24.43% |
CN
|
|
| 6.8081 | 4.31% |
US
|
